Endoxifen API
Lewens Labs develops and manufactures Endoxifen API — active metabolite of tamoxifen (SERM), the pharmacologically active metabolite of tamoxifen — used in hormone receptor-positive breast cancer, at its GMP facility in Gujarat, India.
Note for Lewens: populate CAS, formula, grade, DMF/CEP & registrations for Endoxifen from the Regulatory master list.
Why Endoxifen rewards process depth.
Endoxifen involves stereoselective synthesis with tight E/Z isomer control.
Lewens' integrated platform — process R&D, analytical development and manufacturing under one team — is built for exactly this kind of technically demanding molecule. We can support Endoxifen as commercial supply, as a second source, or as a development and custom-synthesis programme through our CDMO platform.
Three ways to source Endoxifen.
Ongoing supply
Reliable, on-specification commercial quantities of Endoxifen API for your registered product.
Alternate supplier
De-risk your supply chain for Endoxifen with a dependable additional or backup source.
Custom & CDMO
Process development, improvement or exclusive arrangements for Endoxifen under NDA.
More in Oncology.
Endoxifen API — FAQs.
Does Lewens manufacture Endoxifen API?
Can Lewens supply Endoxifen as a second source?
What is Endoxifen used for?
Need Endoxifen API?
Request specifications, samples or DMF/CEP documentation — or discuss a second-source or custom-synthesis programme.
